GoodBelly key facts
as of Oct 2026- Manufacturer of probiotic-enriched beverages and dietary supplements intended for digestive health support.
- GoodBelly is valued at approximately $85.0M as of Oct 2026 (last reported valuation).
- It has raised $55.7M; the latest was Later Stage VC ($10.0M) in Dec 2025.
- Notable investors include 301, Emil Capital Partners, Sadhu Capital.
- Status: Privately Held (backing).
GoodBelly's last reported valuation, Dec 2025. Nothing priced has surfaced since.
- ·Watch GoodBelly: the Monday email on marks, rounds and moves
GoodBelly funding rounds
No funding rounds for GoodBelly are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs GoodBelly
3GoodBelly valuation
GoodBelly's last reported valuation was $85 million in Dec 2025. No priced round, secondary trade or fund mark has surfaced since.
GoodBelly investors
3 investors are on record for GoodBelly, including 301, Emil Capital Partners and Sadhu Capital.
About GoodBelly
Manufacturer of probiotic-enriched beverages and dietary supplements intended for digestive health support. The company's platform features a range of dairy-free juice drinks, concentrated wellness shots, and shelf-stable capsules formulated with clinically studied bacterial strains and prebiotic fibers, enabling health-conscious consumers to maintain optimal intestinal microflora balance, improve nutrient absorption, and bolster immune system function through a variety of natural, plant-based nutritional formats.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Boulder, CO, United States
- Founded
- 2006
- Employees
- 15
- Website
- goodbelly.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.